1. Chronic prurigo: Insufficient disease control in spite of high healthcare usage.
- Author
-
Pereira, Manuel P., Weisshaar, Elke, Halvorsen, Jon Anders, Wallengren, Joanna, Legat, Franz J., Garcovich, Simone, Savk, Ekin, Reich, Adam, Bozek, Agnieszka, Lvov, Andrey, Bobko, Svetlana, Metz, Martin, Streit, Markus, Misery, Laurent, Brenaut, Emilie, Serra‐Baldrich, Esther, Gonçalo, Margarida, Szepietowski, Jacek C., Augustin, Matthias, and Nau, Teresa
- Subjects
- *
PRURIGO , *ITCHING , *PREVENTIVE medicine , *MEDICAL care , *MEDICAL care use - Abstract
(a) Number of ambulatory visits (n = 441), inpatient stays (n = 339) and inpatient stay days (n = 166) per patient due to chronic prurigo in per cent and absolute numbers. y-axis: number of patients. Dermatologists treating adult CPG patients at 14 dermatological centres across 12 European countries completed a questionnaire for each patient. Chronic prurigo (CPG) is a highly pruritic, debilitating disease,[1] complex to treat,[2] with an estimated prevalence of 8.4-210/100,000.[3] Patients are mostly treated by dermatologists and general practitioners, with 33.8% of patients receiving at least one systemic and 45.1% one topical prescription drug.[4] We investigated healthcare utilization and treatment patterns across Europe in a prospective, multicentre study. [Extracted from the article]
- Published
- 2023
- Full Text
- View/download PDF